Lion Point Capital’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $873K | Hold |
98,700
| – | – | 5.93% | 8 |
|
|
2025
Q1 | $773K | Buy |
98,700
+34,700
| +54% | +$272K | 4.93% | 9 |
|
|
2024
Q4 | $673K | Hold |
64,000
| – | – | 3.52% | 13 |
|
|
2024
Q3 | $839K | Sell |
64,000
-18,500
| -22% | -$243K | 1.87% | 12 |
|
|
2024
Q2 | $1.16M | Hold |
82,500
| – | – | 2.11% | 9 |
|
|
2024
Q1 | $1.39M | Buy |
82,500
+2,500
| +3% | +$42.2K | 0.78% | 10 |
|
|
2023
Q4 | $1.13M | Hold |
80,000
| – | – | 0.57% | 12 |
|
|
2023
Q3 | $824K | Buy |
+80,000
| New | +$824K | 0.37% | 15 |
|